Organ cells were used in the early years of cell therapy advancement. They were first practiced in South East Asia roughly around year 2000. It was well known as a complementary biological treatment which was successfully adopted to alleviate symptoms of early ageing and chronic degenerative diseases. Basically, choice active cellular materials are harvested from various specially bred sheep early foetal tissues to activate repair and rejuvenation of the human body. Early foetal cellular materials are more effective than adult cells because in an early foetus, organs such as the liver, spleen, kidney, pituitary and thymus glands are not fully formed yet, and so the cells are very active. The rationale is that young active cells will act as the catalyst to revitalise old cells.
Upon harvesting, the cells undergo a rigorous and complex series of processes, from high tech filtration under stringent conditions, to cryogenic activity and lyophilisation** to preserve the biological composition and integrity of the cells. The lyophilised** cells then can be securely transported around the world and reactivated again through reconstitution (where the lyophilised cells are hydrated with sterilised water).
Once administered into the human body, these cells will travel to their respective tissues and
organs where they activate cellular rejuvenation, and imprint their vigor upon old, tired and damaged cells of the human body. What this means is when the specific organ cell is administered, for example kidney cells, will naturally find its way to the kidney organ after circulating in the body for about 48 hrs. After which rejuvenation activity will initiate by the newly reached young and active kidney cells. This is known as the Homing Principle.
To achieve precise results, the rejuvenation of supporting organs relevant to the damaged organ are required. Together in a synergistic effect, proper organ functions will be achieved.
** The Lyophilisation of Organ Cells factors to date is an exclusive and patented preservation technology. This advanced standard of technology has successfully allowed cell therapy to be stable and readily available, superseding older techniques such as ‘Fresh Frozen’, which is temperature sensitive, risking the integrity of cells.